|
Real-time
Boerse Muenchen
12:44:15 07/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.6500 EUR | +11.11% |
|
-46.82% | - |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Chart: Technical Analysis
Boerse MuenchenEUR
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
Boerse Muenchen
| 25K0 | Real-time | |
|
CBOE
| KPTI | Real-time | |
|
Tradegate
| 25K0 | Real-time | |
|
Deutsche Boerse AG
| 25K0 | Delayed | |
|
Börse Stuttgart
| 25K0 | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- 25K0 Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
